Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease

BACKGROUND: Cardiovascular disease, which is due in part to progressive vascular calcification, is the leading cause of death among patients with end stage kidney disease (ESKD) on dialysis. A role for vitamin K in the prevention of vascular calcification is plausible based on the presence of vitami...

Descripción completa

Detalles Bibliográficos
Autores principales: Holden, Rachel M, Booth, Sarah L, Day, Andrew G, Clase, Catherine M, Zimmerman, Deborah, Moist, Louise, Shea, M Kyla, McCabe, Kristin M, Jamal, Sophie A, Tobe, Sheldon, Weinstein, Jordan, Madhumathi, Rao, Adams, Michael A, Heyland, Daren K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465015/
https://www.ncbi.nlm.nih.gov/pubmed/26075081
http://dx.doi.org/10.1186/s40697-015-0053-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465015/
https://www.ncbi.nlm.nih.gov/pubmed/26075081
http://dx.doi.org/10.1186/s40697-015-0053-x

Ejemplares similares